Washington University’s Center for Vaccines and Immunity to Microbial Pathogens (CVIMP) goal is to facilitate seamless interactions between the tremendous clinical expertise at Washington University School of Medicine (WUSM) and its world-renowned basic science departments.


Known pathogens, such as influenza viruses, HIV, TB, and malaria, and the emergence of new pathogens, such as the Zika virus and SARS-CoV-2, continue to represent frequent and significant threats to human health. Novel or improved vaccines and therapeutics are desperately needed across various infectious disease disciplines.

CVIMP targets all different stages of vaccine development that range from basic vaccine platform development, pivotal animal studies, detailed laboratory-based analysis of immune responses and correlates of protection, GMP production facilities, administrative infrastructure for IND filing, and a clinical trials group that can design and run phase I and II studies.

Our vision is to amplify and accelerate the translational impact of the cutting-edge research performed at WUSM that dissects the interplay between our immune system and microbial pathogens.

Latest Events

2026 Vaccine Research Day

2026 Vaccine Research Day

April 21, 2026

Fort Neuroscience Research Building, Washington University School of Medicine in St. Louis

2026 Rising Stars Seminar Series

2026 Rising Stars Seminar Series

Times: 3-4 PM CST

January 6    Anass Abbad    Icahn School of Medicine Mount Sinai

February 3    Annie Elong Ngono    La Jolla Institute for Immunology

March 10    Zhuoming Liu    Washington University School of Medicine

April 6    Namit Chaudhary    The Scripps Research Institute

May 5    Sumanta Naik    Washington University School of Medicine

June 2    Daniel Malouli    Oregon Health & Science University

July 7    Julianna Han    The Scripps Research Institute

August 4    Bernadeta Dadonaite    Fred Hutchinson Cancer Center

September 1    Mark Painter    Perelman School of Medicine University of Pennsylvania

October 6    Chris Risley    University of Alabama at Birmingham

November 3    Rosie Aogo    National Institutes of Health

December 1    Violeta Capric & Doan Nguyen Emory University

Latest Podcasts

Latest News

Latest Publications

Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates (Links to an external site)

Gagne M, Flynn BJ, Andrew SF, Marquez J, Flebbe DR, Mychalowych A, Lamb E, Davis-Gardner ME, Burnett MR, Serebryannyy LA, Lin BC, Ziff ZE, Maule E, Carroll R, Naisan M, Jethmalani Y, Pessaint L, Todd JM, Doria-Rose NA, Case JB, Dmitriev IP, Kashentseva EA, Ying B, Dodson A, Kouneski K, O’Dell S, Wali B, Ellis M, Godbole S, Laboune F, Henry AR, Teng IT, Wang D, Wang L, Zhou Q, Zouantchangadou S, Van Ry A, Lewis MG, Andersen H, Kwong PD, Curiel DT, Roederer M, Nason MC, Foulds KE, Suthar MS, Diamond MS, Douek DC, Seder RA.

Follow us on social media